Implied volatility shows how much movement the market ... Given the way analysts feel about Globus Medical right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, ...

In November, I believed that shares of Globus Medical (NYSE:GMED ... more than doubled sales to about a billion, making shares trade at highs around $80 in the period 2021-2023.

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to ...

Net income rose by 77% to $26.5 million, highlighting significant growth. Globus Medical's results underscore a strong quarter, with effective execution of strategic initiatives, notably the full ...

For anyone who wants to understand Globus Medical's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$274m due to ...

In trading on Tuesday, shares of Globus Medical Inc (Symbol ... for entry point opportunities on the buy side. The chart below shows the one year performance of GMED shares: Looking at the ...

a global leader in innovative medical technologies, announced it has entered into a non-exclusive licensing agreement with Globus Medical, Inc., a leading musculoskeletal solutions company.

Implied volatility shows how much movement ... Given the way analysts feel about Globus Medical right now, this huge implied volatility could mean there’s a trade developing.

Medical technologies specialist Globus Medical (NYSE:GMED) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS ...